What is Krystexxa?

Krystexxa (pegloticase) is a prescription biologic medication used to treat chronic gout that has not responded to conventional therapies. It works by breaking down uric acid in the bloodstream, preventing its buildup in joints and tissues. Krystexxa is administered as an intravenous (IV) infusion and is often prescribed alongside methotrexate to improve treatment response and reduce the likelihood of adverse reactions.

Side Effects

Gout flares (especially within the first three months of treatment)
Joint pain
Nausea
Fatigue
Bruising
Sore throat
Allergic reactions such as wheezing, shortness of breath, flushing, and swelling of the face or throat

Administration

Duration

3 hours

Cycle

Every 2 weeks

Conditions Krystexxa Treats

See what other infusions we offer

Information coming soon...

Check out our other treatments or contact us with any questions

Why Patients Choose Infusion to Recieve Their Krystexxa Treatment

Infusion Specialists care for patients with complex chronic conditions by redefining the infusion therapy experience. They focus on patient-centered care that transcends traditional medical infusion treatments. 

Redefine your care experience

Private Suites

Leather recliners and space for guests

On your Schedule

Local Centers offer flexible scheduling, including early morning, evenings, and weekends

Goodbye Waiting

Greeted by name at check-in, patient suites are always ready upon arrival

Sit Back and Relax

In-room streaming options and plenty of snacks